Mitch43 wrote: Who being nobody, but the invisible hand of the markets as explained by Scottish philosopher/economist Adam smith economic theories 3 centuries ago adjusted to this century.
Anyone willing to do its own diligence on Reliq health technologies would rapidly come to realise how little can be ascertained about its present 2023 balance sheet ....All we have to rely on so far is still its 2022 EOY audited report which is less than stellar, still not profitable with probably less than 100k onboarded patients (through run rate guesses) , significant AR , nebulous adherence and paid for hardware when compared to all the rosy gooblegihook constantly fed to us by its CEO interviews with selected interviewers about being a rapid growing CO presuming having a long list of unverifiable signed contract s with nameless clients providing access to millions of potential chonic patients to its Hugo platform....
Hence the simplest/comprehensible explanation for its prent low SP and volumes on stock exchanges.
Reliq's management already know its 4th quarter as well as the 2023 EOY financial figures... If they were as good as they anticipated/projected to us, we would already know about it.
I won't attend the webinar, however she should be grilled about the real present number of onboarded client and how could it be ascertained from reliq earnings with run rates.
As for the posters who regularly contact Reliq IR, keep in mind Reliq's IR is sub-contracted to Lythman partners Co', "Scott", which has thus an interest to keep its answers supporting Reliq' narratives....
I'm neither a CO basher, nor a shorter, just a concerned shareholder wishing to be proven wrong since I would benefit from it...Though I'll be surprised if the SP and volume will increase dramatically after the webinar.